|
1
|
Marçôa R, Rodrigues DM, Dias M, Ladeira I,
Vaz AP, Lima R and Guimarães M: Classification of chronic
obstructive pulmonary disease (COPD) according to the new global
initiative for chronic obstructive lung disease (GOLD) 2017:
Comparison with GOLD 2011. COPD. 15:21–26. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
McCullagh BN, Comellas AP, Ballas ZK,
Newell JD Jr, Zimmerman MB and Azar AE: Antibody deficiency in
patients with frequent exacerbations of chronic obstructive
pulmonary disease (COPD). PLoS One. 12:e01724372017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang Z, Wang C and Yang X: Efficacy of
salmeterol and formoterol combination treatment in mice with
chronic obstructive pulmonary disease. Mol Med Rep. 15:1538–1545.
2018.
|
|
4
|
Mohammed J, Derom E, Van Oosterwijck J, Da
Silva H and Calders P: Evidence for aerobic exercise training on
the autonomic function in patients with chronic obstructive
pulmonary disease (COPD): A systematic review. Physiotherapy.
104:36–45. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Engel M, Endesfelder D, Schloter-Hai B,
Kublik S, Granitsiotis MS, Boschetto P, Stendardo M, Barta I, Dome
B, Deleuze JF, et al: Influence of lung CT changes in chronic
obstructive pulmonary disease (COPD) on the human lung microbiome.
PLoS One. 12:e01808592017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Khan DM, Ullah A, Randhawa FA, Iqtadar S,
Butt NF and Waheed K: Role of vitamin D in reducing number of acute
exacerbations in chronic obstructive pulmonary disease (COPD)
patients. Pak J Med Sci. 33:610–4. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Allers M, Langejuergen J, Gaida A, Holz O,
Schuchardt S, Hohlfeld JM and Zimmermann S: Measurement of exhaled
volatile organic compounds from patients with chronic obstructive
pulmonary disease (COPD) using closed gas loop GC-IMS and
GC-APCI-MS. J Breath Res. 10:0260042016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Spero K, Khorfan F and Bayasi G: The over
diagnosis of COPD in hospitalized patients. Chest. 150:921A2016.
View Article : Google Scholar
|
|
9
|
Yang IA, Brown JL, George J, Jenkins S,
McDonald CF, McDonald VM, Phillips K, Smith BJ, Zwar NA and
Dabscheck E: COPD-X Australian and New Zealand guidelines for the
diagnosis and management of chronic obstructive pulmonary disease:
2017 update. Med J Aust. 207:436–442. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Peat R, Furlong J, Byrne T, Young R,
Kangombe A, Elkin T, Renwick S, Russell D, Oelbaum S, Burhan H and
Walke PP: P198 Anchoring copd screening to drug services in heroin
and crack smokers to improve diagnosis. Thorax. 71:A192.1–A192.
2016. View Article : Google Scholar
|
|
11
|
Wang Q, Yu H, Yu H, Ma M, Ma YL and Li R:
miR-223-3p/TIAL1 interaction is involved in the mechanisms
associated with the neuroprotective effects of dexmedetomidine on
hippocampal neuronal cells in vitro. Mol Med Rep.
19:805–812. 2019.PubMed/NCBI
|
|
12
|
Jin R, Hu S, Liu X, Guan R, Lu L and Lin
R: Intranasal instillation of miR-410 targeting IL-4/IL-13
attenuates airway inflammation in OVA-induced asthmatic mice. Mol
Med Rep. 19:895–900. 2019.PubMed/NCBI
|
|
13
|
Shen W, Liu J, Zhao G, Fan M, Song G and
Zhang Y, Weng Z and Zhang Y: Repression of Toll-like receptor-4 by
microRNA-149-3p is associated with smoking-related COPD. Int J
Chron Obstruct Pulmon Dis. 12:705–15. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu X, Qu J, Xue W, He L, Wang J, Xi X,
Liu X, Yin Y and Qu Y: Bioinformatics-based identification of
potential microRNA biomarkers in frequent and non-frequent
exacerbators of COPD. Int J Chron Obstruct Pulmon Dis. 13:1217–28.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sheng Y, Li J, Zou C, Wang S, Cao Y, Zhang
J, Huang A and Tang H: Downregulation of miR-101-3p by hepatitis B
virus promotes proliferation and migration of hepatocellular
carcinoma cells by targeting Rab5a. Arch Virol. 159:2397–2410.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hassan F, Nuovo GJ, Crawford M, Boyaka PN,
Kirkby S, Nana-Sinkam SP and Cormet-Boyaka E: MiR-101 and miR-144
regulate the expression of the CFTR chloride channel in the lung.
PLoS One. 7:e508372012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Arbillaga-Etxarri A, Gimeno-Santos E,
Barberan-Garcia A, Benet M, Borrell E, Dadvand P, Foraster M, Marín
A, Monteagudo M, Rodriguez-Roisin R, et al: Socio-environmental
correlates of physical activity in patients with chronic
obstructive pulmonary disease (COPD). Thorax. 72:796–802. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hoogendoorn M, Feenstra TL, Asukai Y,
Briggs AH, Hansen RN, Leidl R, Risebrough N, Samyshkin Y, Wacker M
and Rutten-van Mölken MP: External validation of health economic
decision models for chronic obstructive pulmonary disease (COPD):
Report of the third COPD modeling meeting. Value Health.
20:397–403. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhao E, Maj T, Kryczek I, Wei L, Ke W,
Zhao L, Wei S, Crespo J, Wan S, Vatan L, et al: Cancer mediates
effector T cell dysfunction by targeting microRNAs and EZH2 via
glycolysis restriction. Nat Immunol. 17:95–103. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pichiorri F, Suh SS, Rocci A, De Luca L,
Taccioli C, Santhanam R, Zhou W, Benson DM Jr, Hofmainster C, Alder
H, et al: Downregulation of p53-inducible microRNAs 192, 194, and
215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma
development. Cancer Cell. 18:367–381. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
O'Leary L, Sevinç K, Papazoglou IM, Tildy
B, Detillieux K, Halayko AJ, Chung KF and Perry MM: Airway smooth
muscle inflammation is regulated by microRNA-145 in COPD. FEBS
Lett. 590:1324–1334. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xu Y, Yao Y, Jiang X, Zhong X, Wang Z, Li
C, Kang P, Leng K, Ji D, Li Z, et al: SP1-induced upregulation of
lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding
EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma. J
Exp Clin Canc Res. 37:812018. View Article : Google Scholar
|
|
24
|
Liang H, Yu T, Han Y, Jiang H, Wang C, You
T, Zhao X, Shan H, Yang R, Yang L, et al: LncRNA PTAR promotes EMT
and invasion-metastasis in serous ovarian cancer by competitively
binding miR-101-3p to regulate ZEB1 expression. Mol Cancer.
17:1192018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hung CH, Hu TH, Lu SN, Kuo FY, Chen CH,
Wang JH, Huang CM, Lee CM, Lin CY, Yen YH and Chiu YC: Circulating
microRNAs as biomarkers for diagnosis of early hepatocellular
carcinoma associated with hepatitis B virus. Int J Cancer.
138:714–720. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Karakas M, Schulte C, Appelbaum S, Ojeda
F, Lackner KJ, Münzel T, Schnabel RB, Blankenberg S and Zeller T:
Circulating microRNAs strongly predict cardiovascular death in
patients with coronary artery disease-results from the large
AtheroGene study. Eur Heart J. 38:516–523. 2017.PubMed/NCBI
|
|
27
|
Ramshankar V and Krishnamurthy A: Lung
cancer detection by screening-presenting circulating miRNAs as a
promising next generation biomarker breakthrough. Asian Pac J
Cancer Prev. 14:2167–2172. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Su H, Yang JR, Xu T, Huang J, Xu L, Yuan Y
and Zhuang SM: MicroRNA-101, down-regulated in hepatocellular
carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer
Res. 69:1135–1142. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen YR, Chen V, Hollander Z, Leipsic JA,
Hague CJ, Demarco ML, FitzGerald JM, McManus BM, Ng RT and Sin DD:
C-reactive protein and N-terminal prohormone brain natriuretic
peptide as biomarkers in acute exacerbations of COPD leading to
hospitalizations. PLoS One. 12:e01740632017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Song Y, Chen R, Zhan Q, Chen S, Luo Z, Ou
J and Wang C: The optimum timing to wean invasive ventilation for
patients with AECOPD or COPD with pulmonary infection. Int J Chron
Obstruct Pulmon Dis. 11:535–542. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mouronte-Roibás C, Leiro-Fernández V,
Ruano-Raviña A, Ramos-Hernández C, Abal-Arca J4, Parente-Lamelas I,
Botana-Rial M, Priegue-Carrera A and Fernández-Villar A: Chronic
obstructive pulmonary disease in lung cancer patients: Prevalence,
underdiagnosis, and clinical characterization. Respiration.
95:414–421. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cosio BG, Soriano JB, López-Campos JL,
Calle-Rubio M, Soler-Cataluna JJ, de-Torres JP, Marín JM,
Martínez-Gonzalez C, de Lucas P, Mir I, et al: Defining the
Asthma-COPD overlap syndrome in a COPD cohort. Chest. 149:45–52.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Green CE and Turner AM: The role of the
endothelium in asthma and chronic obstructive pulmonary disease
(COPD). Resp Res. 18:202017. View Article : Google Scholar
|
|
34
|
Leiro-Fernández V, Priegue Carrera A and
Fernández-Villar A: Efficacy of double bronchodilation (LABA+LAMA)
in patients with chronic obstructive pulmonary disease (COPD) and
lung cancer. Arch Bronconeumol. 52:622–623. 2016.(In English,
Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kokturk N, Baha A, Oh YM, Young Ju J and
Jones PW: Vitamin D deficiency: What does it mean for chronic
obstructive pulmonary disease (COPD)? a compherensive review for
pulmonologists. Clin Respir J. 12:382–397. 2016. View Article : Google Scholar
|
|
36
|
Kim JH, Lee DK, Kim J, Choi S, Park W, Ha
KS, Kim TH, Choe J, Won MH, Kwon YG and Kim YM: A miRNA-101-3p/Bim
axis as a determinant of serum deprivation-induced endothelial cell
apoptosis. Cell Death Dis. 8:e28082017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zou SC, Pang LL, Mao QS, Wu SY and Xiao
QF: IL-9 exacerbates the development of chronic obstructive
pulmonary disease through oxidative stress. Eur Rev Med Pharmacol
Sci. 22:8877–8884. 2018.PubMed/NCBI
|
|
38
|
Kang MJ, Choi LM, Kim BH, Lee CM, Cho WK,
Choe G, Kim DH, Lee CG and Elias JA: IL-18 induces emphysema and
airway and vascular remodeling via IFN-γ, IL-17A, and IL-13. Am J
Respir Crit Care Med. 11:1205–1217. 2012. View Article : Google Scholar
|
|
39
|
Wang Y, Xu J, Meng Y, Adcock IM and Yao X:
Role of inflammatory cells in airway remodeling in COPD. Int J
Chron Obstruct Pulmon Dis. 13:3341–3348. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang HX, Yang JJ, Zhang SA, Zhang SM,
Wang JX, Xu ZY and Lin RY: HIF-1α promotes inflammatory response of
chronic obstructive pulmonary disease by activating EGFR/PI3K/AKT
pathway. Eur Rev Med Pharmacol Sci. 22:6077–6084. 2018.PubMed/NCBI
|
|
41
|
Wang J, Liang H, Ge H, Guo XL, Gu D and
Yuan Y: MicroRNA-363-3p inhibits hepatocarcinogenesis by targeting
HMGA2 and is associated with liver cancer stage. Mol Med Rep.
19:935–942. 2019.PubMed/NCBI
|
|
42
|
Min JH, Yang H, Ivan M, Gertler F, Kaelin
WG Jr and Pavletich NP: Structure of an HIF-1alpha-pVHL complex:
Hydroxyproline recognition in signaling. Science. 296:1886–1889.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Miller F, Kentsis A, Osman R and Pan ZQ:
Inactivation of VHL by tumorigenic mutations that disrupt dynamic
coupling of the pVHL.hypoxia-inducible transcription factor-1alpha
complex. J Biol Chem. 280:7985–7996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Semba H, Takeda N, Isagawa T, Sugiura Y,
Honda K, Wake M, Miyazawa H, Yamaguchi Y, Miura M, Jenkins DM, et
al: HIF-1α-PDK1 axis-induced active glycolysis plays an essential
role in macrophage migratory capacity. Nat Commun. 7:116352016.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Shih JW, Chiang WF, Wu ATH, Wu MH, Wang
LY, Yu YL, Hung YW, Wang WC, Chu CY, Hung CL, et al: Long noncoding
RNA LncHIFCAR/MIR31HG is a HIF-1α co-activator driving oral cancer
progression. Nat Commun. 8:158742017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sundh J and Ekström M: Risk factors for
developing hypoxic respiratory failure in COPD. Int J Chron
Obstruct Pulmon Dis. 12:2095–2100. 2017. View Article : Google Scholar : PubMed/NCBI
|
